120 related articles for article (PubMed ID: 8339126)
1. Lupus anticoagulant as a prognostic marker in systemic lupus erythematosus.
Jouhikainen T; Stephansson E; Leirisalo-Repo M
Br J Rheumatol; 1993 Jul; 32(7):568-73. PubMed ID: 8339126
[TBL] [Abstract][Full Text] [Related]
2. Lupus anticoagulant in systemic lupus erythematosus: a clinical and renal pathological study.
Farrugia E; Torres VE; Gastineau D; Michet CJ; Holley KE
Am J Kidney Dis; 1992 Nov; 20(5):463-71. PubMed ID: 1442758
[TBL] [Abstract][Full Text] [Related]
3. Association of lupus anticoagulant and anticardiolipin antibodies with thrombosis in patients with systemic lupus erythematosus, primary antiphospholipid syndrome and other disorders.
Brenner B; Tavori S; Lerner M; Tatarsky I; Lorber M
Isr J Med Sci; 1992 Jan; 28(1):9-15. PubMed ID: 1733904
[TBL] [Abstract][Full Text] [Related]
4. Increased factor VIIa levels in systemic lupus erythematosus patients with lupus anticoagulant.
Matsuda J; Gohchi K; Kawasugi K
Int J Hematol; 1997 Feb; 65(2):143-9. PubMed ID: 9071818
[TBL] [Abstract][Full Text] [Related]
5. Catastrophic antiphospholipid syndromes in systemic lupus erythematosus.
Stratta P; Canavese C; Ferrero S; Grill A; Salomone M; Schinco PC; Fusaro E; Montaruli B; Santi S; Piccoli G
Ren Fail; 1999 Jan; 21(1):49-61. PubMed ID: 10048117
[TBL] [Abstract][Full Text] [Related]
6. Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus--a meta-analysis.
Wahl DG; Guillemin F; de Maistre E; Perret C; Lecompte T; Thibaut G
Lupus; 1997; 6(5):467-73. PubMed ID: 9229367
[TBL] [Abstract][Full Text] [Related]
7. Thrombotic events in systemic lupus erythematosus. Its association with acquired and inherited thrombophilic defects.
Vayá A; Santaolaria M; Micó L; Calvo J; Oropesa R; Villa P; Todoli J; Simó M; Corella D; Ricart JM
Clin Hemorheol Microcirc; 2008; 40(2):79-87. PubMed ID: 19029633
[TBL] [Abstract][Full Text] [Related]
8. [Retinal vascular lesions in systemic lupus erythematosus and secondary antiphospholipid syndrome].
Ermakova NA; Alekberova ZS; Reshetniak TM; Kalashnikova LA; Kosheleva NM
Vestn Oftalmol; 2005; 121(5):31-6. PubMed ID: 16274063
[TBL] [Abstract][Full Text] [Related]
9. Increased C1q, C4 and C3 deposition on platelets in patients with systemic lupus erythematosus--a possible link to venous thrombosis?
Lood C; Eriksson S; Gullstrand B; Jönsen A; Sturfelt G; Truedsson L; Bengtsson AA
Lupus; 2012 Nov; 21(13):1423-32. PubMed ID: 22878256
[TBL] [Abstract][Full Text] [Related]
10. Deep venous thrombosis and a circulating anticoagulant in systemic lupus erythematosus.
St Clair W; Jones B; Rogers JS; Crouch M; Hrabovsky E
Am J Dis Child; 1981 Mar; 135(3):230-2. PubMed ID: 7211777
[TBL] [Abstract][Full Text] [Related]
11. Transiently positive anticardiolipin antibodies and risk of thrombosis in patients with systemic lupus erythematosus.
Martinez-Berriotxoa A; Ruiz-Irastorza G; Egurbide MV; Garmendia M; Gabriel Erdozain J; Villar I; Aguirre C
Lupus; 2007; 16(10):810-6. PubMed ID: 17895304
[TBL] [Abstract][Full Text] [Related]
12. High prevalence of thrombocytopenia in SLE patients with a high level of anticardiolipin antibodies combined with lupus anticoagulant.
Nojima J; Suehisa E; Kuratsune H; Machii T; Toku M; Tada H; Yamaguti K; Koike T; Kanakura Y; Kitani T; Amino N
Am J Hematol; 1998 May; 58(1):55-60. PubMed ID: 9590150
[TBL] [Abstract][Full Text] [Related]
13. Recurrent antiphospholipid-related deep vein thrombosis as presenting manifestation of systemic lupus erythematosus.
Gattorno M; Molinari AC; Buoncompagni A; Acquila M; Amato S; Picco P
Eur J Pediatr; 2000 Mar; 159(3):211-4. PubMed ID: 10664237
[TBL] [Abstract][Full Text] [Related]
14. Lupus anticoagulant in Thai systemic lupus erythematosus patients.
Intragumtornchai T; Akkawat B; Mahasandana S; Watananukul P; Deesomchok U
Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():241-5. PubMed ID: 7886586
[TBL] [Abstract][Full Text] [Related]
15. Lupus anticoagulant in children with thrombosis.
Manco-Johnson MJ; Nuss R
Am J Hematol; 1995 Apr; 48(4):240-3. PubMed ID: 7717372
[TBL] [Abstract][Full Text] [Related]
16. Thrombosis in systemic lupus erythematosus: a French collaborative study.
Montes de Oca MA; Babron MC; Blétry O; Broyer M; Courtecuisse V; Fontaine JL; Loirat C; Méry JP; Reinert P; Wechsler B
Arch Dis Child; 1991 Jun; 66(6):713-7. PubMed ID: 1905123
[TBL] [Abstract][Full Text] [Related]
17. [Following 90 patients with antiphospholipid syndrome with antibody titers and correlations with clinical manifestations: symptoms of the disease, a new antibody and correlations with clinical manifestations in the Israeli population].
Marai I; Levi Y; Godard G; Shoenfeld Y
Harefuah; 2001 Jun; 140(6):495-500, 565. PubMed ID: 11420848
[TBL] [Abstract][Full Text] [Related]
18. Risk of arterial thrombosis in patients with anticardiolipin antibodies and lupus anticoagulant.
Nojima J; Suehisa E; Akita N; Toku M; Fushimi R; Tada H; Kuratsune H; Machii T; Kitani T; Amino N
Br J Haematol; 1997 Mar; 96(3):447-50. PubMed ID: 9054646
[TBL] [Abstract][Full Text] [Related]
19. Antiphospholipid antibodies in paediatric systemic lupus erythematosus, juvenile chronic arthritis and overlap syndromes: SLE patients with both lupus anticoagulant and high-titre anticardiolipin antibodies are at risk for clinical manifestations related to the antiphospholipid syndrome.
Gattorno M; Buoncompagni A; Molinari AC; Barbano GC; Morreale G; Stalla F; Picco P; Mori PG; Pistoia V
Br J Rheumatol; 1995 Sep; 34(9):873-81. PubMed ID: 7582730
[TBL] [Abstract][Full Text] [Related]
20. Platelet activation induced by combined effects of anticardiolipin and lupus anticoagulant IgG antibodies in patients with systemic lupus erythematosus--possible association with thrombotic and thrombocytopenic complications.
Nojima J; Suehisa E; Kuratsune H; Machii T; Koike T; Kitani T; Kanakura Y; Amino N
Thromb Haemost; 1999 Mar; 81(3):436-41. PubMed ID: 10102474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
